| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XRAY | Common Stock | Award | $0 | +6,098 | $0 | 6,098 | 04 Mar 2022 | Direct | F1 | |
| transaction | XRAY | Common Stock | Award | $0 | +18,762 | +3.08% | $0 | 24,860 | 04 Mar 2022 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XRAY | Stock Option (Right to Buy) | Award | $0 | +21,200 | $0 | 21,200 | 04 Mar 2022 | Common Stock | 21,200 | $53.3 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending March 4, 2025. |
| F2 | Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 4, 2025. |